Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

Google Creates New Formats To Include Risk Information In Sponsored Search Results

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Click-through rate on health condition search results declined dramatically since FDA citations, company says.

You may also be interested in...



Google Platform Changes Spur Pharma Rethinking Of Search Engine Ads

Widespread use of paid ads that display disease-specific website address differing significantly from destination hyperlink for branded product will end in January.

Google Platform Changes Spur Pharma Rethinking Of Search Engine Ads

Widespread use of paid ads that display disease-specific website address differing significantly from destination hyperlink for branded product will end in January.

Google Platform Changes Spur Pharma Rethinking Of Search Engine Ads

Widespread use of paid ads that display disease-specific website address differing significantly from destination hyperlink for branded product will end in January.

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet

Topics

Tags:
BioPharmaceutical
Latest Headlines

Finding The Sweet Spot For Real-World Evidence: Aetion Stresses Early Feasibility Assessment

FDA Gene Therapy Office Chief Prefers Flexibility With Accelerated Approval Confirmatory Trials

Keeping Track: Return & Renewal At US FDA

Korean Bioclusters Offer Tax, Other Incentives To Attract Global Firms, Talent

See All
UsernamePublicRestriction

Register

PS068740

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By